Overview
AI-driven small molecule design now part of Recursion.
Details
Valence Labs builds geometric deep learning for drug design and was acquired by Recursion in 2023.
AI-driven small molecule design now part of Recursion. Valence Labs builds geometric deep learning for drug design and was acquired by Recursion in 2023.
AI-driven small molecule design now part of Recursion.
Valence Labs builds geometric deep learning for drug design and was acquired by Recursion in 2023.
Turn AI reports into shareable sites
Publish reports & dashboards as websites
Make AI-generated reports public, stable, and easy to update — free to start.
Try Revdoku →